Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CalciMedica, Inc. Common Stock

CALC
Current price
3.5 USD -0.07 USD (-1.96%)
Last closed 3.47 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 46 741 596 USD
Yield for 12 month +2.94 %
1Y
3Y
5Y
10Y
15Y
CALC
21.11.2021 - 28.11.2021

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated (CRAC) channel inhibitors, which is in phase 2 clinical trials for the treatment of acute pancreatitis, asparaginase induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops CM6336, an oral CRAC channel inhibitors for chronic inflammatory indications; and Auxora, for the treatment of acute ulcerative colitis and allergic asthma. The company is based in La Jolla, California. Address: 505 Coast Boulevard South, La Jolla, CA, United States, 92037

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

17 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-58 000 USD

Last Year

-52 000 USD

Current Quarter

-15 000 USD

Last Quarter

-15 000 USD

Key Figures CALC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -21 388 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -64.92 %
PEG Ratio
Return On Equity TTM -83.76 %
Wall Street Target Price 17 USD
Revenue TTM
Book Value 1.29 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.17 USD
Diluted Eps TTM -0.17 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CALC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CALC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:14
Payout Ratio
Last Split Date 20.03.2023
Dividend Date

Stock Valuation CALC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.2563
Price Book MRQ 3.3778

Financials CALC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CALC

For 52 weeks

2.68 USD 8.38 USD
50 Day MA 4.19 USD
Shares Short Prior Month 37 691
200 Day MA 4.61 USD
Short Ratio 1.41
Shares Short 34 158
Short Percent 0.59 %